Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Minority Interest (2016 - 2021)

Historic Minority Interest for Myriad Genetics (MYGN) over the last 5 years, with Q3 2021 value amounting to -$100000.0.

  • Myriad Genetics' Minority Interest changed N/A to -$100000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was -$100000.0, marking a year-over-year change of. This contributed to the annual value of -$400000.0 for FY2017, which is N/A changed from last year.
  • Per Myriad Genetics' latest filing, its Minority Interest stood at -$100000.0 for Q3 2021.
  • Myriad Genetics' 5-year Minority Interest high stood at $100000.0 for Q1 2018, and its period low was -$400000.0 during Q2 2017.
  • Moreover, its 4-year median value for Minority Interest was -$100000.0 (2018), whereas its average is -$133333.3.
  • Data for Myriad Genetics' Minority Interest shows a peak YoY increase of 20000.0% (in 2019) and a maximum YoY decrease of 20000.0% (in 2019) over the last 5 years.
  • Over the past 4 years, Myriad Genetics' Minority Interest (Quarter) stood at -$300000.0 in 2017, then soared by 66.67% to -$100000.0 in 2018, then surged by 200.0% to $100000.0 in 2019, then tumbled by 200.0% to -$100000.0 in 2021.
  • Its last three reported values are -$100000.0 in Q3 2021, -$100000.0 for Q2 2021, and $100000.0 during Q4 2019.